15902
19712
Nippon India Pharma Fund - Direct (G)
22.59
6.53
13.49
-1.72
2.65
3.64
3.54
17.30
7
1.88
13.49
Nippon India Pharma Fund - Direct (G)
1.8
12.48
1.19
3.5
5 Years

SIP TrendupInvest in Mutual Funds at 0 Transaction cost

Start Investing
  • NAV

    595.36

    03 Jun 2026

  • 0.28%

     1 Day

  • 22.59%

    3Y CAGR returns

Note: Data shown is for Direct Plan. Our Platform offers Regular Plans only. Returns may differ due to expense ratio differences.
One click to compare funds with our smart tool—analyze returns & more! Compare
  • ₹ 100

    Min SIP
  • ₹ 5000

    Min Lumpsum
  • 0.93%

    Expense Ratio
  • 3

    Rating
  • 8,365 Cr

    Fund Size
  • 13 Years

    Fund Age

SIP Calculator

Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00
Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00

Returns and Ranks ( as on 03 Jun 2026 )

  • 1Y Returns
  • 3Y Returns
  • 5Y Returns
  • MAX Returns
  • Trailing Returns
  • 6.53%
  • 22.59%
  • 13.49%
  • 17.30
7.95%
7.04%
6.61%
5.47%
59.08%
View All
  • 14.67Alpha
  • 4.54SD
  • 0.75Beta
  • 0.96Sharpe
  • Exit Load
  • 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
  • Tax implication
  • Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Low Low to
moderate
Moderate Moderately
High
High Very
High
  • Address :
  • 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
    • Contact :
    • +91022-68087000/1860260111
    • Email ID :
    • customercare@nipponindiaim.in

FAQs

Nippon India Pharma Fund - Direct (G) has delivered 18.85% since inception

The NAV of Nippon India Pharma Fund - Direct (G) is ₹511.22 as of 03 Jun 2026

The expense ratio of Nippon India Pharma Fund - Direct (G) is 0.93 % as of 03 Jun 2026

The AUM of Nippon India Pharma Fund - Direct (G) 7160.93 CR as of 03 Jun 2026

The minimum SIP amount of Nippon India Pharma Fund - Direct (G) is 100

The top stock holdings of Nippon India Pharma Fund - Direct (G) are

  1. Sun Pharma.Inds. - 13.85%
  2. Lupin - 7.95%
  3. Dr Reddy's Labs - 7.04%
  4. Divi's Lab. - 6.61%
  5. Cipla - 5.47%

The top sectors Nippon India Pharma Fund - Direct (G) has invested in are

  1. Pharmaceuticals & Biotech - 77.63%
  2. Healthcare Services - 17.57%
  3. Retailing - 3.14%
  4. Debt - 1.79%
  5. Cash & Others - -0.13%

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form